Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Upexi (UPXI) Cash & Equivalents (2020 - 2026)

Upexi's Cash & Equivalents history spans 7 years, with the latest figure at $3.5 million for Q1 2026.

  • On a quarterly basis, Cash & Equivalents rose 1411.7% to $3.5 million in Q1 2026 year-over-year; TTM through Mar 2026 was $3.5 million, a 1411.7% increase, with the full-year FY2025 number at $3.0 million, up 349.82% from a year prior.
  • Cash & Equivalents hit $3.5 million in Q1 2026 for Upexi, up from $1.6 million in the prior quarter.
  • Over the last five years, Cash & Equivalents for UPXI hit a ceiling of $7.1 million in Q2 2022 and a floor of $224318.0 in Q1 2024.
  • Historically, Cash & Equivalents has averaged $2.3 million across 5 years, with a median of $1.8 million in 2024.
  • Biggest five-year swings in Cash & Equivalents: crashed 87.43% in 2023 and later surged 1411.7% in 2026.
  • Tracing UPXI's Cash & Equivalents over 5 years: stood at $4.5 million in 2022, then tumbled by 87.43% to $566677.0 in 2023, then decreased by 28.29% to $406347.0 in 2024, then soared by 297.88% to $1.6 million in 2025, then surged by 115.42% to $3.5 million in 2026.
  • Business Quant data shows Cash & Equivalents for UPXI at $3.5 million in Q1 2026, $1.6 million in Q4 2025, and $2.2 million in Q3 2025.